|
| UNITAID Project Support | Title
| Partners | UNITAID contribution disbursed in 2007 in US$ (millions)
| Key Objective(s) for 2007 | Key Achievements
|
|
| HIV/AIDS | |
| | | |
| HIV/AIDS Paediatric ARV project (2006-08)
| Clinton Foundation HIV/AIDS initiative (CHAI)
| 26.5 | New paediatric ARV formulations
| 19 paediatric formulations including new fixed dose combinations (FDC).
|
| | |
| Provision of treatment to children | 62,000 additional children treated; 40,000 continued on treatment.
|
| | |
| Price reduction on paediatric ARVs | Average price reduction of 40% on paediatric ARVs.
|
| 2nd line HIV/AIDS Programme (2007-08)
| Clinton Foundation HIV/AIDS initiative (CHAI)
| 35.9 | Price reduction in 2nd line ARVs
| Average price reduction of 23% in low income countries and a 49% price reduction in middle income countries.
|
| | |
| Provision of ARV treatments supplied | 29,000 2nd line treatments and 25,000 Tenofovir 1st line treatments supplied.
|
| Acceleration of Prevention of Mother-to-Child Transmission (PMTCT) and Scale-Up (2007-09)
| UNICEF, WHO | 6.47 | Provision of more efficacious ARV regimens to women and their new born.
Provision of co-trimoxazole prophylaxis for the prevention of opportunistic infections
| Following signature of Agreement in December 2007, 1st disbursement made December 2007: orders for commodities placed.
|
| | |
| Accelerate the scale-up of HIV testing and counselling in antenatal, maternity and postpartum services
| Implementation Letters sent out to the 8 countries and UNITAID-funded PMTCT activities incorporated into country plans for PMTCT interventions in countries.
|
| Malaria | |
| | | |
| ACT Scale-up Initiative 2007-11
| Global Fund, UNICEF | 15.6 |
To support scale up ACT treatment for malaria control through Global Fund grants in 8 countries
| Following signature of MOU in December 2007, 1st disbursement made in the same month. Letters of implementation dispatched. Revisions to GF Grant Agreements made to reflect increase in target treatments attributable to UNITAID funding. Tendering and Long Term Agreements under way. Prequalification of two ACTs and approximately 16 ACT-combination products submitted for Prequalification. Arrangements with suppliers regarding buffer stocks at their premises in place.
|
| UNITAID Project Support for Emergency ACTs for Liberia and Burundi, 2007
| UNICEF, WHO | 1.3 | To fill the gaps in ACT treatment courses in Burundi and Liberia and to prevent disruptions in ACT treatments in these countries
| 722 953 ACT treatments delivered in Burundi in August 2007.
678 858 ACT treatments delivered in Liberia in June 2007.
|
| TB | |
| | | |
| First Line anti-TB drugs-add to reflect purpose (to avoid stock outs until alternative funding sources become available) (2007-09)
| Stop TB Partnership, Global Drug Facility |
22.5 | Timely provision to 19 countries of 1st line TB drugs.
| Orders for the 19 countries for 1st Line Drugs in accordance with schedule developed.
|
| | |
| Creation of strategic rotating stockpile for 1st line drugs to (i)reduce delivery lead times, (ii) reduce overall treatment costs for drug deliveries and (iii) prevent stock outs
| Competitive tender for stockpile launched and selection in process.
|
| | |
| Cost containment at below 20 USD for a 6 month treatment with WHO standard FDC
| Cost containment at below 20 USD for a 6 month treatment with WHO standard FDC secured.
|
| MDR-TB Scale-Up (2007-11) |
Green Light Committee, Global Drug Facility, and the Global Fund
| 7.1 | Price reduction | Competitive prices secured via direct negotiation.
|
| | |
| Provision of 2nd line anti-TB drugs for 17 beneficiary countries
| 2nd line anti-TB drugs orders placed for 2 out of 17 beneficiary countries
|
| | |
| Rotating stockpile production | Procurement agent contracted and stockpiling production initiated.
|
| Support to Paediatric TB (2006-07)
| Global Drug Facility | 5.7 |
Identification of paediatric TB suppliers | 4 paediatric TB suppliers under contract
|
| | |
| Supply of 150,000 paediatric anti-Tuberculosis (TB) treatments for children in 20 countries.
| 150'000 treatments being supplied.
Impact of pooled procurement has generated significant price reductions for paediatric anti-TB drugs.
|
| | |
| Agreement amended scale-up supply of an additional 450'000 paediatric anti-Tuberculosis (TB) treatments in an additional 20 countries
| As a consequence, of cost savings, scale-up process initiated.
|
| | |
| Price containment | Competitive prices secured via direct negotiation
|
| Transversal Projects |
| | | |
|
| Support to WHO Prequalification Programme (2007)
| WHO | 6 | Prequalification of UNITAID priority medicines
| 21 drugs pre-qualified in 2007 for TB, HIV/AIDS and Malaria.
|
| | |
| Field sampling and quality testing | Laboratories identified in 4 pilot Products and protocols being finalized in view of implementation.
|
| UNITAID Support for Global Fund Round 6, Phase 1
| Global Fund, WHO | 0 | To support the Round 6 through a contribution of 52.5 million for the provision of ACTs, 2nd Line and Paediatric ARVs and MDR-TB treatments.
| Memorandum of Understanding signed December 2007 and implementation according to Global Fund country grants commenced.
|
|
